login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
OVID THERAPEUTICS INC (OVID) Stock News
USA
- NASDAQ:OVID -
US6904691010
-
Common Stock
1.35
USD
0 (0%)
Last: 11/11/2025, 8:00:02 PM
1.37
USD
+0.02 (+1.48%)
After Hours:
11/11/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
OVID Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Zacks Investment Research
- Mentions:
MNKD
MannKind (MNKD) Tops Q3 Earnings and Revenue Estimates
7 days ago - By: Zacks Investment Research
- Mentions:
ANAB
AnaptysBio, Inc. (ANAB) Surpasses Q3 Earnings and Revenue Estimates
8 days ago - By: Zacks Investment Research
- Mentions:
RNA
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
23 days ago - By: Zacks Investment Research
- Mentions:
UNH
GS
PSA
MU
...
Take the Zacks Approach to Beat the Market: UnitedHealth, Ovid, Micron in Focus
6 months ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results
a month ago - By: Stocktwits
- Mentions:
BSVO
VXF
Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why
a month ago - By: Benzinga
- Mentions:
CCCC
DBVT
ACIU
CLPT
...
12 Health Care Stocks Moving In Friday's Pre-Market Session
a month ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
a month ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
a month ago - By: Ovid Therapeutics Inc.
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
a month ago - By: Ovid Therapeutics Inc.
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
3 months ago - By: Yahoo Finance
Lucid Capital Initiates Ovid Therapeutics Inc. (OVID) at Buy with $5.50 Target
3 months ago - By: Benzinga
- Mentions:
CDXS
VSTM
PULM
SNOA
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
3 months ago - By: Zacks Investment Research
- Mentions:
OCS
Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates
3 months ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
3 months ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
4 months ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
4 months ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
5 months ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
5 months ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
5 months ago - By: Yahoo Finance
- Mentions:
TSLA
NUVB
Are These 2 'Strong Buy' Rated Growth Stocks Buys Right Now?
5 months ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
5 months ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
6 months ago - By: Zacks Investment Research
- Mentions:
CVAC
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
6 months ago - By: Ovid Therapeutics Inc.
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results
6 months ago - By: Zacks Investment Research
- Mentions:
FTRE
Fortrea Holdings Inc. (FTRE) Q1 Earnings and Revenues Beat Estimates
6 months ago - By: Zacks Investment Research
- Mentions:
ANIP
ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates
6 months ago - By: Zacks Investment Research
- Mentions:
JAZZ
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates
6 months ago - By: Zacks Investment Research
- Mentions:
IBRX
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Please enable JavaScript to continue using this application.